| Hsu-ling Hseu Hsieh, OT | |
|
320 S Garfield Ave, 302, Alhambra, CA 91801-6816 | |
| (626) 300-8341 | |
| (626) 300-8767 |
| Full Name | Hsu-ling Hseu Hsieh |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 41 Years |
| Location | 320 S Garfield Ave, Alhambra, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295091478 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chang-yu J Hsieh | 6103725742 | 2 |
News Archive
Astellas Pharma Inc., a global pharmaceutical company, and AVEO Pharmaceuticals, Inc. today announced that they have entered into a worldwide agreement outside of Asia to develop and commercialize tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers.
Glioblastoma multiforme is a particularly deadly cancer. A person diagnosed with this type of brain tumor typically survives 15 months, if given the best care. The late Senator Ted Kennedy succumbed to this disease in just over a year.
Critics of the overhaul argued that, as passed by Congress, the statutory language limited the use of subsidies to purchase health insurance only to consumers in states that are running their own online marketplaces - not to those who are shopping for health plans on the federal exchange. The judge's ruling, which upholds a central element of the health law, is a victory for the Obama administration.
ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, confirms its JETREA US launch date of Monday January 14th, 2013.
› Verified 4 days ago
| Provider Name | Chang-yu J Hsieh |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1831105634 PECOS PAC ID: 6103725742 Enrollment ID: O20040102000699 |
News Archive
Astellas Pharma Inc., a global pharmaceutical company, and AVEO Pharmaceuticals, Inc. today announced that they have entered into a worldwide agreement outside of Asia to develop and commercialize tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers.
Glioblastoma multiforme is a particularly deadly cancer. A person diagnosed with this type of brain tumor typically survives 15 months, if given the best care. The late Senator Ted Kennedy succumbed to this disease in just over a year.
Critics of the overhaul argued that, as passed by Congress, the statutory language limited the use of subsidies to purchase health insurance only to consumers in states that are running their own online marketplaces - not to those who are shopping for health plans on the federal exchange. The judge's ruling, which upholds a central element of the health law, is a victory for the Obama administration.
ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, confirms its JETREA US launch date of Monday January 14th, 2013.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hsu-ling Hseu Hsieh, OT 320 S Garfield Ave, 302, Alhambra, CA 91801-6816 Ph: (626) 300-8341 | Hsu-ling Hseu Hsieh, OT 320 S Garfield Ave, 302, Alhambra, CA 91801-6816 Ph: (626) 300-8341 |
News Archive
Astellas Pharma Inc., a global pharmaceutical company, and AVEO Pharmaceuticals, Inc. today announced that they have entered into a worldwide agreement outside of Asia to develop and commercialize tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers.
Glioblastoma multiforme is a particularly deadly cancer. A person diagnosed with this type of brain tumor typically survives 15 months, if given the best care. The late Senator Ted Kennedy succumbed to this disease in just over a year.
Critics of the overhaul argued that, as passed by Congress, the statutory language limited the use of subsidies to purchase health insurance only to consumers in states that are running their own online marketplaces - not to those who are shopping for health plans on the federal exchange. The judge's ruling, which upholds a central element of the health law, is a victory for the Obama administration.
ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, confirms its JETREA US launch date of Monday January 14th, 2013.
› Verified 4 days ago
Guadalupe Yessenia Rodriguez, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Fremont Ave Unit 27, Alhambra, CA 91803 Phone: 562-333-3700 | |
Mei Shan Anita Chie, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 58 S 5th St Apt G, Alhambra, CA 91801 Phone: 469-569-2998 | |
Alexis Whitman, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 315 W Grand Ave, Apt B, Alhambra, CA 91801 Phone: 805-559-2181 | |
Jilianne Lauren Normandy, MS Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Fremont Ave Bldg A10n, Alhambra, CA 91803 Phone: 626-289-7472 | |
Shangmiaw Lin Sheu, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1118 S Garfield Ave, Suite #203, Alhambra, CA 91801 Phone: 626-284-6888 Fax: 626-289-5686 | |
Louisie Buzi, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Fremont Ave Unit 27, Alhambra, CA 91803 Phone: 626-289-7472 | |
Natalie Marie Loera, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Fremont Ave Unit 27, Alhambra, CA 91803 Phone: 213-607-4400 |